Concepedia
Statistics
Publications
16
Citations
664
H-Index
13
Active since
2014
Affiliations
Institute of Cancer Research(Current)
Imperial College London
Hammersmith Hospital
Royal Marsden NHS Foundation Trust
Newcastle University
Gilberto S. Almeida is an author at Institute of Cancer Research specializing in medicine, oncology, and pharmacology.
Publications per year
2014–2024
The effect of FASN inhibition on the growth and metabolism of a cisplatin‐resistant ovarian carcinoma model
Efthymia Papaevangelou, Gilberto S. Almeida, Carol Box et al. · International Journal of Cancer · 2018 · 121 citations · Full text
Medicine, Oncology, Pharmacology +17
<i>In Vivo</i> Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis
Orli Yogev, Gilberto S. Almeida, Karen Barker et al. · Cancer Research · 2019 · 80 citations · Full text
Medicine, Cancer Biology, Oncology +15
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma
Evon Poon, Tong Liang, Yann Jamin et al. · Journal of Clinical Investigation · 2020 · 70 citations · Full text
Medicine, Oncology, Pharmacology +16
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
Elizabeth Hardaker, Emilio Sanseviero, Ankur Karmokar et al. · Nature Communications · 2024 · 59 citations · Full text
Medicine, Immunology, Pharmacology +17
Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy
Efthymia Papaevangelou, Gilberto S. Almeida, Yann Jamin et al. · British Journal of Cancer · 2015 · 56 citations · Full text
1–5 of 16